Albemarle (ALB) EBIT (2009 - 2026)

Albemarle (ALB) has 18 years of EBIT data on file, last reported at $501.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 2435.12% year-over-year to $501.0 million; the trailing twelve-month figure through Mar 2026 stood at $864.0 million (up 154.78% YoY), and the FY2025 full-year result was -$367.1 million, up 79.34% from the prior year.
• EBIT for Q1 2026 stood at $501.0 million, up from $197.9 million in the prior quarter.
• Across five years, EBIT topped out at $1.1 billion in Q1 2023 and bottomed at -$1.1 billion in Q3 2024.
• The 5-year median for EBIT is $117.6 million (2025), against an average of $107.6 million.
• The widest annual swing landed in 2024, when EBIT sank 691.94%; it then soared 4396.46% in 2025.
• A 5-year view of EBIT shows it stood at $833.0 million in 2022, then plunged by 202.02% to -$849.9 million in 2023, then soared by 100.52% to $4.4 million in 2024, then jumped by 4396.46% to $197.9 million in 2025, then jumped by 153.1% to $501.0 million in 2026.
• The last three EBIT figures came in at $501.0 million (Q1 2026), $197.9 million (Q4 2025), and $117.6 million (Q3 2025), per Business Quant data.

Peer Comparison